2009•Critical CareOpen access

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome

Б. Чарра, Abdelhamid Hachimi, A. Benslama, S. Motaouakkil

Abstract

Annually, Guillain-Barré syndrome (GBS) affects one to four cases/100,000. Intravenous immunoglobulins (IVIg) and plasma exchange (PE) are the main treatment in this disease. The purpose of this study is to compare the efficacy of IVIg versus PE in the treatment of GBS in a medical ICU.

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Guillain-Barre syndrome, Intravenous Immunoglobulins, Antibody, Plasmapheresis, Therapeutic plasma exchange, Pediatrics, Intensive care medicine